Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POEM: Temsirolimus in Endometrial Carcinoma
NCT02093598Phase 2Completed
- Sponsor
- MEDSIR
- Start
- May 2012
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temsirolimus in endometrial carcinoma, sponsored by MEDSIR. Started May 2012; status: completed.
02
Drugs
temsirolimus
03
Conditions
endometrial carcinoma
Beyond the preview
Go deeper on NCT02093598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02093598.